Shares of The Marzetti Company plunged 7.1% to $103.00 in pre-market trading after the specialty food maker reported first-quarter adjusted earnings per share of $1.14, badly missing the Street's $1.36 consensus estimate — a shortfall of roughly 16%. For a stock that had been quietly climbing over the prior week from $107.81 to $110.93, the reversal is a jarring reminder that operational headwinds haven't faded. Marzetti's Cyclospora Hangover Drags Earnings Far Below Estimates — Can the Company Recover Its Momentum?
Shares of The Marzetti Company cratered 7.1% to $103.00 before the opening bell after the specialty food maker delivered first-quarter fiscal 2027 earnings of $1.14 per share — badly missing the $1.37 consensus estimate by roughly 17%. CEO Dave Ciesinski acknowledged that "the cyclospora outbreak had a significant impact on this quarter's top and bottom-line results." For shareholders of this usually predictable packaged-food stock, the miss is the worst in at least five quarters and signals the food-safety crisis is extracting a heavier toll than Wall Street anticipated.
• The Damage Was Worse Than Management's Own Warning — On its Q4 2026 call, Marzetti warned that the Cyclospora outbreak would cause a 250-basis-point sales headwind in Q1, with flattish revenue and a roughly 15% decline in operating income. The actual results overshot even that downbeat guide: adjusted operating income fell $16.6 million to $43.9 million , while consolidated net sales declined 2.4% to $481.5 million . The implication is that consumer pullback from salad and dressing products — Marzetti's core — ran deeper and lasted longer than the company's own models predicted.
• Costs Piled On While Sales Shrank — Selling, general and administrative expenses jumped $10.9 million to $69.3 million , driven partly by integration spending for Bachan's, the Japanese barbecue sauce brand acquired in fiscal 2026. When revenue is falling and overhead is rising, profit margins get squeezed from both directions — exactly what investors saw this morning.
• The Bachan's Acquisition Offered Only Partial Shelter — Retail segment sales rose 2.0% to $252.7 million, boosted by $17.8 million of incremental Bachan's revenue. Strip that out and legacy retail sales actually declined, underscoring that the Cyclospora scare weighed on shopper appetite across dressing and salad categories. Foodservice revenue dropped 6.9%, or 2.6% excluding a now-expired supply agreement.
• Investors Must Weigh a Temporary Setback Against Lingering Risk — The CDC declared this outbreak over on September 11 and confirmed that contaminated lettuce is no longer in stores. Yet Marzetti trades at roughly 15× trailing earnings, and the question is whether shoppers' dressing habits snap back quickly or whether the brand carries a food-safety stigma into the holiday season — the company's most important selling period. Management's full-year plan still calls for moderate inflation offset by pricing and cost savings , but today's numbers show that plan has almost no margin for error.